If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSND.L Regulatory News (SND)

  • There is currently no data for SND

Regulatory Condition to Conditional Subscription

29 May 2024 07:00

RNS Number : 1680Q
Sondrel (Holdings) plc
29 May 2024
 

29 May 2024

 

Sondrel (Holdings) plc

("Sondrel", the "Company" and together with its subsidiaries the "Group")

 

Regulatory Condition to Conditional £5.6m Subscription

 

Sondrel (AIM: SND), a leading provider of ultra-complex chips for leading global technology brands, announced on 14 May 2024 that it had conditionally raised gross proceeds of £5,625,400 pursuant to a subscription by ROX Equity Partners Limited for 56,254,000 new ordinary shares in the Company at an issue price of 10 pence per new ordinary share (the "Subscription").

 

The Subscription remains conditional upon, inter alia, Sondrel independent shareholder approval at a general meeting to be held on 30 May 2024 (the "General Meeting") and approval by the UK secretary of state of ROX's proposed investment in the Company as required by the National Security and Investment Act 2021 ("NSIA Approval").

 

Sondrel announces that it has now been informed that NSIA Approval is unlikely to be received prior to the General Meeting. As such it is currently anticipated that admission of the new ordinary shares to be issued pursuant to the Subscription will take place after 31 May 2024, but prior to the agreed long stop date of 8:00 am on 13 June 2024.

 

A further announcement in connection with the status of the NSIA Approval, together with an updated admission date, will be made in due course as and when appropriate.

 

 

For further information:

 

Sondrel (Holdings) plc

Via Buchanan

David Mitchard, Interim CEO

Tel: +44 (0) 20 7466 5000

Nick Stone, Interim CFO

Cavendish Capital Markets Limited

Tel: +44 (0) 20 7220 0500

Ben Jeynes / Katy Birkin / George Lawson - Corporate Finance

Michael Johnson / Charlie Combe - Sales and ECM

Buchanan Communications

Tel: +44 (0) 20 7466 5000

Chris Lane

Stephanie Whitmore

sondrel@buchanan.uk.com

 

Jack Devoy

Abby Gilchrist

 

About Sondrel

Sondrel is a UK-based fabless semiconductor company specialising in high end, complex digital Application Specific Integrated Circuits (ASICs) and System on Chips (SOCs). It provides a full turnkey service in the design, prototyping, testing, packaging and production of ASICs and SoCs.

 

The Company is one of only a few companies capable of designing and supplying the higher-spec chips built on the most advanced semiconductor technologies, selling into a range of hyper growth end markets such as high-performance computing, automotive, artificial intelligence, VR/AR, video analytics, image processing, mobile networking and data centres. Sondrel designs have enabled products by leading technology brands including Apple (iPhone), Sony (PlayStation), Meta's (Oculus), Samsung, Google and Sony smartphones, JVC (prosumer camcorders), Tesla and Mercedes-Benz cars.

 

Sondrel is well-established, with a 20-year track record of successful delivery, supported by long standing ecosystem partnerships including Arm, TSMC and Samsung. Headquartered in the UK, Sondrel has a global presence with offices in UK, USA, China, India and Morocco.

 

For more information please visit: ir.sondrel.com.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBRGDUGUDDGSI
Date   Source Headline
3rd Mar 20154:31 pmRNSResult of AGM
3rd Mar 20157:00 amRNSAGM Statement
2nd Mar 201511:57 amRNSTR-1 Holding in Company: Replacement
2nd Mar 20157:02 amRNSTotal Voting Rights
2nd Mar 20157:00 amRNSHolding in Company
27th Feb 201511:00 amRNSHolding(s) in Company
10th Feb 20158:45 amRNSExercise of Options
31st Dec 20148:00 amRNSTotal Voting Rights
18th Dec 20149:41 amRNSExercise of Options
16th Dec 20147:00 amRNSExercise of Options
12th Dec 20148:41 amRNSPosting of 2014 Annual Report
25th Nov 20147:00 amRNS2014 Final Results
23rd Oct 20147:00 amRNSPre-close Trading Update
5th Sep 20148:00 amRNSHolding(s) in Company
13th Aug 20149:00 amRNSTR1 Holding in Company
13th Aug 20149:00 amRNSTR1 Holding in Company
31st Jul 20148:30 amRNSTotal Voting Rights
7th Jul 20145:09 pmRNSExercise of Options
30th Jun 20145:11 pmRNSTotal Voting Rights
18th Jun 20149:00 amRNSExercise of Options
16th Jun 20143:14 pmRNSTR1: Holding in Company
13th Jun 20144:16 pmRNSHolding(s) in Company
13th Jun 201410:51 amRNSDirector's Dealings
9th Jun 20147:00 amRNS2014 Interim Results
30th Apr 201410:38 amRNSTotal Voting Rights
23rd Apr 20147:00 amRNSPre-Close Trading Update
16th Apr 20147:00 amRNSExercise of Options
31st Mar 20144:31 pmRNSDirectors' Dealings: Exercise of Share Options
31st Mar 20144:29 pmRNSTotal Voting Rights
3rd Mar 20147:00 amRNSResult of AGM
28th Feb 20147:01 amRNSAGM Statement
10th Feb 20147:02 amRNSHolding in Company
3rd Feb 20147:00 amRNSGrant & Exercise of Options
31st Jan 20142:50 pmRNSTotal Voting Rights
29th Jan 20147:00 amRNSGrant and exercise of Options
31st Dec 20139:30 amRNSTotal Voting Rights
23rd Dec 201311:18 amRNSDirectors' Dealings following exercise of Options
18th Dec 20137:00 amRNSGrant & Exercise of Share Options by Directors
6th Dec 20132:00 pmRNSPosting of 2013 Annual Report & Accounts
3rd Dec 20133:46 pmRNSHolding in Company
26th Nov 20137:00 amRNS2013 Final Results
4th Nov 201310:00 amRNSHolding(s) in Company
31st Oct 20138:00 amRNSTotal Voting Rights
30th Oct 201312:34 pmRNSHolding(s) in Company
25th Oct 20132:31 pmRNSResult of EGM and Share Placing Details
25th Oct 20137:00 amRNSPre Close Trading Update
17th Oct 201310:06 amRNSHolding(s) in Company
8th Oct 20137:00 amRNS£5.4m Acquisition and £3.5m Placing of New Shares
28th Aug 20133:16 pmRNSHolding in Company
28th Aug 20137:06 amRNSHolding in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.